Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mari Morita‐Fujita"'
Autor:
Mari Morita-Fujita, Yasuyuki Arai, Satoshi Yoshioka, Takayuki Ishikawa, Junya Kanda, Tadakazu Kondo, Takashi Akasaka, Yasunori Ueda, Kazunori Imada, Toshinori Moriguchi, Kazuhiro Yago, Toshiyuki Kitano, Akihito Yonezawa, Masaharu Nohgawa, Akifumi Takaori-Kondo, Kyoto Stem Cell Transplantation Group (KSCTG)
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Since the introduction of leukemia-type induction therapies for T-cell lymphoblastic lymphoma (T-LBL), improvements in the long-term outcomes of T-LBL have been reported. However, indications for and the appropriate timing of hematopoietic s
Externí odkaz:
https://doaj.org/article/33bb1f49f6f144e8930823840ad60891
Autor:
Mari Morita‐Fujita, Yasuyuki Arai, Tadakazu Kondo, Kaito Harada, Naoyuki Uchida, Takashi Toya, Yukiyasu Ozawa, Takahiro Fukuda, Shuichi Ota, Makoto Onizuka, Yoshinobu Kanda, Yumiko Maruyama, Satoru Takada, Toshiro Kawakita, Takahide Ara, Tatsuo Ichinohe, Takafumi Kimura, Yoshiko Atsuta, Shinichi Kako
Publikováno v:
Hematological Oncology. 40(5):1041-1055
The medium-dose etoposide (VP16) added on cyclophosphamide (CY)/total body irradiation (TBI) is one of the intensified myeloablative conditioning regimens used in allogenic hematopoietic stem cell transplantation (allo-HSCT) for acute lymphoblastic l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2a38a93cbbd9ee79be6314e267b84b4
http://hdl.handle.net/2433/279368
http://hdl.handle.net/2433/279368
Autor:
Kaito Harada, Mari Morita-Fujita, Takahiro Fukuda, Yukiyasu Ozawa, Noriko Doki, Masako Toyosaki, Yumiko Maruyama, Yoshinobu Kanda, Takashi Ashida, Tetsuya Eto, Satoru Takada, Naoyuki Uchida, Tatsuo Ichinohe, Junya Kanda, Makoto Onizuka, Yoshiko Atsuta, Shinichi Kako, Yasuyuki Arai
Publikováno v:
Cytotherapy. 24(9):954-961
BACKGROUND AIMS: An intensified conditioning regimen incorporating medium-dose etoposide (VP16) is an option for patients with acute lymphoblastic leukemia (ALL). However, the prognostic impacts of the addition of VP16 to cyclophosphamide (CY) and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a2a83ed39a08b98ae07817b41d606a
http://hdl.handle.net/2433/279365
http://hdl.handle.net/2433/279365
Autor:
Satoshi Nishiwaki, Yu Akahoshi, Mari Morita-Fujita, Hiroaki Shimizu, Naoyuki Uchida, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Kazuhiro Ikegame, Shuichi Ota, Yuta Katayama, Satoshi Takahashi, Toshiro Kawakita, Takahide Ara, Makoto Onizuka, Takafumi Kimura, Junji Tanaka, Yoshiko Atsuta, Yasuyuki Arai
Publikováno v:
Blood Advances. 6:4558-4569
Allogeneic hematopoietic cell transplantation (allo-HCT) is a promising treatment for adult acute lymphoblastic leukemia (ALL), an intractable hematological malignancy. The trends in allo-HCT outcomes over the past 30 years were examined to verify th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43a817724dcf533fda86d1a054227fb7
https://doi.org/10.1182/bloodadvances.2022008032
https://doi.org/10.1182/bloodadvances.2022008032
Autor:
Mari Morita-Fujita, Takero Shindo, Tomoki Iemura, Yasuyuki Arai, Junya Kanda, Kazuya Okada, Yasunori Ueda, Onda Yoshiyuki, Naoyuki Anzai, Takuto Mori, Takayuki Ishikawa, Yasuyuki Otsuka, Akihito Yonezawa, Naoki Yuhi, Kazunori Imada, Akifumi Oba, Mitsuru Itoh, Yoshio Okamoto, Toshiyuki Kitano, Takashi Ikeda, Shinichi Kotani, Takashi Akasaka, Kazuhiro Yago, Mitsumasa Watanabe, Masaharu Nohgawa, Masaaki Tsuji, Tomoharu Takeoka, Ryusuke Yamamoto, Nobuyoshi Arima, Noriyoshi Yoshinaga, Masakatsu Hishizawa, Kouhei Yamashita, Tadakazu Kondo, Akifumi Takaori-Kondo
Publikováno v:
Transplantation and Cellular Therapy. 29:347.e1-347.e11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2f00864a4aa8a2b659cf3fca342c4a1
https://doi.org/10.1016/j.jtct.2023.03.002
https://doi.org/10.1016/j.jtct.2023.03.002
Autor:
Satoshi Nishiwaki, Yu Akahoshi, Mari Morita-Fujita, Hiroaki Shimizu, Naoyuki Uchida, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Kazuhiro Ikegame, Shuichi Ota, Yuta Katayama, Satoshi Takahashi, Toshiro Kawakita, Takahide Ara, Makoto Onizuka, Takahumi Kimura, Junji Tanaka, Yoshiko Atsuta, Yasuyuki Arai
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a8edbbcdfe2b166f1cd10c2dab698b1
https://doi.org/10.2139/ssrn.4052662
https://doi.org/10.2139/ssrn.4052662
Autor:
Satoshi Yoshioka, Nobuhiro Hiramoto, Hiroharu Imoto, Mari Morita-Fujita, Daisuke Yamashita, Takayuki Ishikawa
Publikováno v:
Bone Marrow Transplantation. 56:1743-1745
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616fa914e8bcaed010ade635ea76e5f2
https://doi.org/10.1038/s41409-021-01263-4
https://doi.org/10.1038/s41409-021-01263-4
Publikováno v:
Clinical lymphoma, myelomaleukemia. 19(7)
Background Patients with relapsed or refractory peripheral T-cell lymphoma, not otherwise specified (R/R-PTCL-NOS) usually have short survival with conventional salvage chemotherapies. Prediction of poor survival in patients who undergo conventional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::750b0f187e14ee5ca5962cf258a4ca3e
https://pubmed.ncbi.nlm.nih.gov/31053551
https://pubmed.ncbi.nlm.nih.gov/31053551
Autor:
Mari, Morita-Fujita, Tomohiro, Yabushita, Yoshimitsu, Shimomura, Yuichiro, Ono, Nobuhiro, Hiramoto, Satoshi, Yoshioka, Noboru, Yonetani, Akiko, Matsushita, Hisako, Hashimoto, Takayuki, Ishikawa
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 59(7)
Optimal salvage chemotherapy has not been established for patients with acute myeloid leukemia (AML) who fail to attain complete remission (CR) after one course of induction chemotherapy. This retrospective study aimed to assess the efficacy and safe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfe6be2ac3d5acf9415747fef2f79efc
https://pubmed.ncbi.nlm.nih.gov/30078794
https://pubmed.ncbi.nlm.nih.gov/30078794